Obesity affects 41% of Americans, and with the recent rise in popularity of GLP-1 drugs, more people are looking to use them to achieve their weight-loss goals. However, these drugs are expensive to both employees and the plan overall. This week, Jackie Warren, Director of Data and Reporting for Engagement Health Group, joins this week's episode to discuss how to GLP-1s should be utilized to both achieve weight-loss goals and keep plan costs low.